Real-time study of prostate intrafraction motion during external beam radiotherapy with daily endorectal balloon
- PMID: 21035952
- DOI: 10.1016/j.ijrobp.2010.08.052
Real-time study of prostate intrafraction motion during external beam radiotherapy with daily endorectal balloon
Abstract
Purpose: To prospectively investigate intrafraction prostate motion during radiofrequency-guided prostate radiotherapy with implanted electromagnetic transponders when daily endorectal balloon (ERB) is used.
Methods and materials: Intrafraction prostate motion from 24 patients in 787 treatment sessions was evaluated based on three-dimensional (3D), lateral, cranial-caudal (CC), and anterior-posterior (AP) displacements. The mean percentage of time with 3D, lateral, CC, and AP prostate displacements>2, 3, 4, 5, 6, 7, 8, 9, and 10 mm in 1 minute intervals was calculated for up to 6 minutes of treatment time. Correlation between the mean percentage time with 3D prostate displacement>3 mm vs. treatment week was investigated.
Results: The percentage of time with 3D prostate movement>2, 3, and 4 mm increased with elapsed treatment time (p<0.05). Prostate movement>5 mm was independent of elapsed treatment time (p=0.11). The overall mean time with prostate excursions>3 mm was 5%. Directional analysis showed negligible lateral prostate motion; AP and CC motion were comparable. The fraction of time with 3D prostate movement>3 mm did not depend on treatment week of (p>0.05) over a 4-minute mean treatment time.
Conclusions: Daily endorectal balloon consistently stabilizes the prostate, preventing clinically significant displacement (>5 mm). A 3-mm internal margin may sufficiently account for 95% of intrafraction prostate movement for up to 6 minutes of treatment time. Directional analysis suggests that the lateral internal margin could be further reduced to 2 mm.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
A study to quantify the effectiveness of daily endorectal balloon for prostate intrafraction motion management.Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1055-63. doi: 10.1016/j.ijrobp.2011.07.038. Epub 2011 Nov 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 22115790
-
An endorectal balloon reduces intrafraction prostate motion during radiotherapy.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):661-9. doi: 10.1016/j.ijrobp.2011.07.028. Epub 2011 Nov 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22099035
-
Prostate and patient intrafraction motion: impact on treatment time-dependent planning margins for patients with endorectal balloon.Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):755-61. doi: 10.1016/j.ijrobp.2013.02.035. Epub 2013 Apr 12. Int J Radiat Oncol Biol Phys. 2013. PMID: 23582854
-
A comparison between hydrogel spacer and endorectal balloon: An analysis of intrafraction prostate motion during proton therapy.J Appl Clin Med Phys. 2017 Mar;18(2):106-112. doi: 10.1002/acm2.12051. Epub 2017 Feb 25. J Appl Clin Med Phys. 2017. PMID: 28300377 Free PMC article.
-
Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review.Pract Radiat Oncol. 2024 Mar-Apr;14(2):146-153. doi: 10.1016/j.prro.2023.08.017. Epub 2023 Oct 22. Pract Radiat Oncol. 2024. PMID: 37875222 Review.
Cited by
-
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.Radiat Oncol. 2020 Jul 22;15(1):178. doi: 10.1186/s13014-020-01622-3. Radiat Oncol. 2020. PMID: 32698843 Free PMC article.
-
Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial.BJU Int. 2020 Feb;125(2):215-225. doi: 10.1111/bju.14925. Epub 2019 Nov 8. BJU Int. 2020. PMID: 31614071 Free PMC article. Clinical Trial.
-
Target margins in radiotherapy of prostate cancer.Br J Radiol. 2016 Nov;89(1067):20160312. doi: 10.1259/bjr.20160312. Epub 2016 Jul 20. Br J Radiol. 2016. PMID: 27377353 Free PMC article. Review.
-
ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy.Int J Part Ther. 2024 Apr 25;13:100021. doi: 10.1016/j.ijpt.2024.100021. eCollection 2024 Sep. Int J Part Ther. 2024. PMID: 39347377 Free PMC article.
-
Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.Med Phys. 2011 Aug;38(8):4623-33. doi: 10.1118/1.3604152. Med Phys. 2011. PMID: 21928635 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical